Osteonecrosis of the Jaw in Multiple Myeloma Patients: Clinical Features and Risk Factors
Top Cited Papers
- 20 February 2006
- journal article
- hematologic malignancies
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (6), 945-952
- https://doi.org/10.1200/jco.2005.04.2465
Abstract
Purpose To describe the clinical, radiologic, and pathologic features and risk factors for osteonecrosis of the jaw (ONJ) in multiple myeloma (MM) patients. Patients and Methods A retrospective rev...Keywords
This publication has 37 references indexed in Scilit:
- Myeloma bone diseaseBest Practice & Research Clinical Haematology, 2005
- Osteonecrosis of the Jaw and BisphosphonatesThe New England Journal of Medicine, 2005
- Bisphosphonate‐associated osteonecrosis of mandibular and maxillary boneCancer, 2005
- Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 casesJournal of Oral Pathology & Medicine, 2005
- Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label studyRheumatology, 2005
- Ethnicity-Related Gastric Cancer SurvivalJournal of Clinical Oncology, 2003
- Modified Fibonacci SearchJournal of Clinical Oncology, 2003
- Review of 1027 Patients With Newly Diagnosed Multiple MyelomaMayo Clinic Proceedings, 2003
- The antitumor potential of bisphosphonatesSeminars in Oncology, 2002
- Novel Antiangiogenic Effects of the Bisphosphonate Compound Zoledronic AcidJournal of Pharmacology and Experimental Therapeutics, 2002